CCEOP Global Service Partner Annual Conference Got Success

On December 15, 2020 (Tuesday), Haier Biomedical successfully held the first online CCEOP Global Service Partner Annual Conference. Service partners from more than 40 countries attended the live online meeting and many shared their previous service experience from 2020. During the conference, 19 service partners were awarded for their efforts and contributions in 2019 and 2020.

For last three years, Haier Biomedical had successfully supplied more than 30,000 vaccine cold chain units to more than 30 countries covering Asia, Eastern Europe, Latin-America and Africa. As at the end of the year 2019, Haier Biomedical had close to 27% of the CCEOP market. For the Service Network of CCEOP projects, the network covers more than 50 countries with diversified partners in the industry from medical, new energy, logistics as well project management. More than 400 local technical staff had been trained by Haier Biomedical and more than 600 jobs have been directly created by the service bundle initiative.

For the COVID-19 vaccine storage requirements at -70℃, -20℃ and 2-8℃, Haier Biomedical can provide the complete solution in different levels and needs depending on the market or region. This includes the national level cold room, the district level vaccine refrigerator, as well as SDD options for regions that have none or intermittent electricity availability. In addition, at Haier Biomedical we are also recommending the temperature monitoring device plus the intelligent stock management system to help clients to collect data from the last mile.

Haier Biomedical is the world's leading biomedical cryogenic cold chain manufacturer covering the full temperature range of -196°C to +8°C. After more than ten years of development, Haier Biomedical has 187 patents including 32 invention patents to date.

The fruits Haier Biomedical has achieved to date cannot be separated from the joint effort of its highly qualified staff, firm insistence of innovation, strong brand culture, long-inscribed sense of corporate social responsibility, and the trust and support of all its partners.

Now, at the end of 2020, we highly appreciate everyone for taking part in Haier Biomedical’s development during the tough but fruitful year, and we sincerely hope that we will create a brighter future together in 2021!